sb 203580 has been researched along with pentoxifylline in 2 studies
| Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (pentoxifylline) | Trials (pentoxifylline) | Recent Studies (post-2010) (pentoxifylline) |
|---|---|---|---|---|---|
| 3,489 | 4 | 1,137 | 4,437 | 657 | 943 |
| Protein | Taxonomy | sb 203580 (IC50) | pentoxifylline (IC50) |
|---|---|---|---|
| Acetylcholinesterase | Homo sapiens (human) | 6.6 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujita, H; Fujiwara, N; Kawakami, H; Nakajima, T; Ueda, Y | 1 |
| Abrahamsen, MS; Maheswaran, SK; Malazdrewich, C; Thumbikat, P | 1 |
2 other study(ies) available for sb 203580 and pentoxifylline
| Article | Year |
|---|---|
Novel piperidinylpyrimidine derivatives as inhibitors of HIV-1 LTR activation.
Topics: Animals; Anti-HIV Agents; Cells, Cultured; HIV Long Terminal Repeat; HIV-1; Humans; Inhibitory Concentration 50; Jurkat Cells; Mice; Pyrimidines; Transcriptional Activation; Tumor Necrosis Factor-alpha | 2008 |
Pharmacological inhibition of Mannheimia haemolytica lipopolysaccharide and leukotoxin-induced cytokine expression in bovine alveolar macrophages.
Topics: Animals; Anti-Inflammatory Agents; Cattle; Cells, Cultured; Cytokines; Dexamethasone; Exotoxins; Gene Expression Regulation; Imidazoles; Interleukin-1; Interleukin-8; Lipopolysaccharides; Macrophages, Alveolar; Mannheimia haemolytica; Pentoxifylline; Pyridines; RNA, Messenger; Rolipram; Tetrahydropapaveroline; Thalidomide; Tumor Necrosis Factor-alpha | 2004 |